Roflumilast Therapeutic Cheat Sheet
RoflumilastRoflumilast is a non-steroidal topical cream that was FDA approved for the treatment of plaque psoriasis in 2022.1 Roflumilast selectively inhibits phosphodiesterase-4 (PDE-4), which is an enzyme that mediates inflammatory responses and has been shown to play a role in several dermatologic diseases.2 Prior to topical roflumilast, oral PDE-4 inhibitors have been investigated across a wide variety o …
Roflumilast
Patient Buzz Series: Skin Smoothies
skin smoothiesThe skin smoothie is one of the latest skincare trends popularized on TikTok. Made famous by TikTok creator Amy K, skin smoothies involve mixing several skincare products and applying the mixture to the skin at the same time. The most popular combination on TikTok involves mixing petroleum jelly, moisturizing lotion, serum and self-tanning lotion. Users claim applying the products together leads t …
skin smoothies
Friday Pop Quiz #227
The correct answer is D. Topical corticosteroids. Involvement of the umbilicus with urticarial papules and plaques progressing into vesicles and bullae is most consistent with pemphigoid gestationis, also called herpes gestationis. The first-line treatment of pemphigoid gestationis is topical corticosteroids. Early delivery at 36 weeks and ursodeoxycholic acid may be treatment options fo …
JDD July 2023 Issue Highlights | Special Focus: Bridging The Gap in Dermatology
dermatologyCheck out this month’s issue highlights straight from the JDD Editor’s desk: Assessing Implicit Bias in Dermatology analyses the results of a survey conducted with 220 dermatologists to determine the necessity for enhanced training and resources in order to support the increasingly diverse population. Modified Fitzpatrick Scale-Skin Color and Reactivity presents a new system that can hel …
dermatology
Friday Pop Quiz #225
The correct answer is: E. Acitretin. The shown lesion is consistent with psoriasis, and systemic therapy can be associated with immunosuppression leading to infection. However, only acitretin of the options listed is non-immunosuppressive and thus should be the first systemic therapy in patients with concerns for immunosuppression. The remaining answer choices are less ideal considering …
error

Enjoy this blog? Please spread the word :)